![]() The Guardian |
Aiming for clinical excellence
The Guardian Called liposomal doxorubicin, it was first used as a treatment for Kaposi's sarcoma, a cancer often associated with Aids. Doxorubicin had been around as a cancer drug since the 1960s. What was new was its encapsulation in a liposome carrier. ... |
Read the full story:
Aiming for clinical excellence - The Guardian

You must log in to post a comment.